STAT1-S727 - the license to kill

Por Putz, Eva M., Gotthardt, Dagmar, Sexl, Veronika
Publicado no Oncoimmunology (2014)

STAT1 Ser727 – key regulator for NK cell-mediated cytotoxicity and tumor surveillance

Por Putz, Eva M, Zebedin-Brandl, Eva, Prchal, Michaela, Decker, Thomas, Kovarik, Pavel, Sexl, Veronika
Publicado em 2008

Unexpected role of STAT1 serine727 for NK cell function

Por Putz, Eva M, Zebedin, Eva, Csiszar, Agnes, Prchal, Michaela, Berger, Angelika, Decker, Thomas, Kovarik, Pavel, Sexl, Veronika
Publicado em 2009

PI3Kδ is indispensable for CTL-mediated cytotoxicity

Por Putz, Eva M, Prchal, Michaela, Simma, Olivia, Forster, Florian, Koenig, Xaver, Piekorz, Roland, Freissmuth, Michael, Sexl, Veronika, Zebedin, Eva-Maria
Publicado em 2011

Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis

Por Putz, Eva M., Guillerey, Camille, Kos, Kevin, Stannard, Kimberley, Miles, Kim, Delconte, Rebecca B., Takeda, Kazuyoshi, Nicholson, Sandra E., Huntington, Nicholas D., Smyth, Mark J.
Publicado no Oncoimmunology (2017)

NK cell heparanase controls tumor invasion and immune surveillance

Por Putz, Eva M., Mayfosh, Alyce J., Kos, Kevin, Barkauskas, Deborah S., Nakamura, Kyohei, Town, Liam, Goodall, Katharine J., Yee, Dean Y., Poon, Ivan K.H., Baschuk, Nikola, Souza-Fonseca-Guimaraes, Fernando, Hulett, Mark D., Smyth, Mark J.
Publicado no J Clin Invest (2017)

Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance

Por Mizutani, Tatsuaki, Neugebauer, Nina, Putz, Eva M., Moritz, Nadine, Simma, Olivia, Zebedin-Brandl, Eva, Gotthardt, Dagmar, Warsch, Wolfgang, Eckelhart, Eva, Kantner, Hans-Peter, Kalinke, Ulrich, Lienenklaus, Stefan, Weiss, Siegfried, Strobl, Birgit, Müller, Mathias, Sexl, Veronika, Stoiber, Dagmar
Publicado em 2012